#BEGIN_DRUGCARD DB03661

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
17285

# Chemical_Formula:
C3H7NO5S

# Chemical_IUPAC_Name:
(2R)-2-amino-3-sulfopropanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Beta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep&#39;s fleece, where the wool is exposed to light and weather. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Cysteinesulfonic Acid

# HET_ID:
OCS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1

# InChI_Key:
InChIKey=XVOYSCVBGLVSOL-REOHCLBHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3661

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
169.156

# Molecular_Weight_Mono:
169.004493029

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1MZS

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-0.36

# Predicted_Water_Solubility:
7.36e+01 g/l

# Primary_Accession_No:
DB03661

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
72886

# PubChem_Substance_ID:
46508940

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02415

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CS(O)(=O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:29 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Cytoplasm

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
M77744

# Drug_Target_10_GenBank_ID_Protein:
145898

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
fabH

# Drug_Target_10_Gene_Sequence:
>954 bp
ATGTATACGAAGATTATTGGTACTGGCAGCTATCTGCCCGAACAAGTGCGGACAAACGCC
GATTTGGAAAAAATGGTGGACACCTCTGACGAGTGGATTGTCACTCGTACCGGTATCCGC
GAACGCCACATTGCCGCGCCAAACGAAACCGTTTCAACCATGGGCTTTGAAGCGGCGACA
CGCGCAATTGAGATGGCGGGCATTGAGAAAGACCAGATTGGCCTGATCGTTGTGGCAACG
ACTTCTGCTACGCACGCTTTCCCGAGCGCAGCTTGTCAGATTCAAAGCATGTTGGGCATT
AAAGGTTGCCCGGCATTTGACGTTGCAGCAGCCTGCGCAGGTTTCACCTATGCATTAAGC
GTAGCCGATCAATACGTGAAATCTGGGGCGGTGAAGTATGCTCTGGTCGTCGGTTCCGAT
GTACTGGCGCGCACCTGCGATCCAACCGATCGTGGGACTATTATTATTTTTGGCGATGGC
GCGGGCGCTGCGGTGCTGGCTGCCTCTGAAGAGCCGGGAATCATTTCCACCCATCTGCAT
GCCGACGGTAGTTATGGTGAATTGCTGACGCTGCCAAACGCCGACCGCGTGAATCCAGAG
AATTCAATTCATCTGACGATGGCGGGCAACGAAGTCTTCAAGGTTGCGGTAACGGAACTG
GCGCACATCGTTGATGAGACGCTGGCGGCGAATAATCTTGACCGTTCTCAACTGGACTGG
CTGGTTCCGCATCAGGCTAACCTGCGTATTATCAGTGCAACGGCGAAAAAACTCGGTATG
TCTATGGATAATGTCGTGGTGACGCTGGATCGCCACGGTAATACCTCTGCGGCCTCTGTC
CCGTGCGCGCTGGATGAAGCTGTACGCGACGGGCGCATTAAGCCGGGGCAGTTGGTTCTG
CTTGAAGCCTTTGGCGGTGGATTCACCTGGGGCTCCGCGCTGGTTCGTTTCTAG

# Drug_Target_10_General_Function:
Lipid transport and metabolism

# Drug_Target_10_General_References:
10593943	Qiu X, Janson CA, Konstantinidis AK, Nwagwu S, Silverman C, Smith WW, Khandekar S, Lonsdale J, Abdel-Meguid SS: Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. J Biol Chem. 1999 Dec 17;274(51):36465-71.
10673437	Davies C, Heath RJ, White SW, Rock CO: The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli. Structure. 2000 Feb 15;8(2):185-95.
11078736	Zhang YM, Rao MS, Heath RJ, Price AC, Olson AJ, Rock CO, White SW: Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III. J Biol Chem. 2001 Mar 16;276(11):8231-8. Epub 2000 Nov 14.
11243824	Qiu X, Janson CA, Smith WW, Head M, Lonsdale J, Konstantinidis AK: Refined structures of beta-ketoacyl-acyl carrier protein synthase III. J Mol Biol. 2001 Mar 16;307(1):341-56.
11375394	Khandekar SS, Gentry DR, Van Aller GS, Warren P, Xiang H, Silverman C, Doyle ML, Chambers PA, Konstantinidis AK, Brandt M, Daines RA, Lonsdale JT: Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH). J Biol Chem. 2001 Aug 10;276(32):30024-30. Epub 2001 May 24.
1314802	Verwoert II, Verbree EC, van der Linden KH, Nijkamp HJ, Stuitje AR: Cloning, nucleotide sequence, and expression of the Escherichia coli fabD gene, encoding malonyl coenzyme A-acyl carrier protein transacylase. J Bacteriol. 1992 May;174(9):2851-7.
1339356	Magnuson K, Oh W, Larson TJ, Cronan JE Jr: Cloning and nucleotide sequence of the fabD gene encoding malonyl coenzyme A-acyl carrier protein transacylase of Escherichia coli. FEBS Lett. 1992 Mar 16;299(3):262-6.
1447160	Oh W, Larson TJ: Physical locations of genes in the rne (ams)-rpmF-plsX-fab region of the Escherichia coli K-12 chromosome. J Bacteriol. 1992 Dec;174(23):7873-4.
1551888	Tsay JT, Oh W, Larson TJ, Jackowski S, Rock CO: Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. J Biol Chem. 1992 Apr 5;267(10):6807-14.
8631920	Heath RJ, Rock CO: Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli. J Biol Chem. 1996 May 3;271(18):10996-1000.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
615

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
33515

# Drug_Target_10_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 3

# Drug_Target_10_Number_of_Residues:
317

# Drug_Target_10_PDB_ID:
1HNK

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF08541	ACP_syn_III_C
PF08545	ACP_syn_III

# Drug_Target_10_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 3
MYTKIIGTGSYLPEQVRTNADLEKMVDTSDEWIVTRTGIRERHIAAPNETVSTMGFEAAT
RAIEMAGIEKDQIGLIVVATTSATHAFPSAACQIQSMLGIKGCPAFDVAAACAGFTYALS
VADQYVKSGAVKYALVVGSDVLARTCDPTDRGTIIIFGDGAGAAVLAASEEPGIISTHLH
ADGSYGELLTLPNADRVNPENSIHLTMAGNEVFKVAVTELAHIVDETLAANNLDRSQLDW
LVPHQANLRIISATAKKLGMSMDNVVVTLDRHGNTSAASVPCALDEAVRDGRIKPGQLVL
LEAFGGGFTWGSALVRF

# Drug_Target_10_Reaction:
an acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = a 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for acetyl-CoA. Its substrate specificity determines the biosynthesis of straight-chain of fatty acids instead of branched-chain

# Drug_Target_10_SwissProt_ID:
P0A6R0

# Drug_Target_10_SwissProt_Name:
FABH_ECOLI

# Drug_Target_10_Synonyms:
3-oxoacyl- [acyl-carrier-protein] synthase III
Beta-ketoacyl-ACP synthase III
EC 2.3.1.41
EcFabH
KAS III

# Drug_Target_10_Theoretical_pI:
4.89

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Endoplasmic reticulum
cytoplasmic side
endoplasmic reticulum membrane
peripheral membrane protein

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
PTPN1

# Drug_Target_11_GenBank_ID_Gene:
M31724

# Drug_Target_11_GenBank_ID_Protein:
190742

# Drug_Target_11_GeneCard_ID:
PTPN1

# Drug_Target_11_Gene_Name:
PTPN1

# Drug_Target_11_Gene_Sequence:
>1308 bp
ATGGAGATGGAAAAGGAGTTCGAGCAGATCGACAAGTCCGGGAGCTGGGCGGCCATTTAC
CAGGATATCCGACATGAAGCCAGTGACTTCCCATGTAGAGTGGCCAAGCTTCCTAAGAAC
AAAAACCGAAATAGGTACAGAGACGTCAGTCCCTTTGACCATAGTCGGATTAAACTACAT
CAAGAAGATAATGACTATATCAACGCTAGTTTGATAAAAATGGAAGAAGCCCAAAGGAGT
TACATTCTTACCCAGGGCCCTTTGCCTAACACATGCGGTCACTTTTGGGAGATGGTGTGG
GAGCAGAAAAGCAGGGGTGTCGTCATGCTCAACAGAGTGATGGAGAAAGGTTCGTTAAAA
TGCGCACAATACTGGCCACAAAAAGAAGAAAAAGAGATGATCTTTGAAGACACAAATTTG
AAATTAACATTGATCTCTGAAGATATCAAGTCATATTATACAGTGCGACAGCTAGAATTG
GAAAACCTTACAACCCAAGAAACTCGAGAGATCTTACATTTCCACTATACCACATGGCCT
GACTTTGGAGTCCCTGAATCACCAGCCTCATTCTTGAACTTTCTTTTCAAAGTCCGAGAG
TCAGGGTCACTCAGCCCGGAGCACGGGCCCGTTGTGGTGCACTGCAGTGCAGGCATCGGC
AGGTCTGGAACCTTCTGTCTGGCTGATACCTGCCTCCTGCTGATGGACAAGAGGAAAGAC
CCTTCTTCCGTTGATATCAAGAAAGTGCTGTTAGAAATGAGGAAGTTTCGGATGGGGTTG
ATCCAGACAGCCGACCAGCTGCGCTTCTCCTACCTGGCTGTGATCGAAGGTGCCAAATTC
ATCATGGGGGACTCTTCCGTGCAGGATCAGTGGAAGGAGCTTTCCCACGAGGACCTGGAG
CCCCCACCCGAGCATATCCCCCCACCTCCCCGGCCACCCAAACGAATCCTGGAGCCACAC
AATGGGAAATGCAGGGAGTTCTTCCCAAATCACCAGTGGGTGAAGGAAGAGACCCAGGAG
GATAAAGACTGCCCCATCAAGGAAGAAAAAGGAAGCCCCTTAAATGCCGCACCCTACGGC
ATCGAAAGCATGAGTCAAGACACTGAAGTTAGAAGTCGGGTCGTGGGGGGAAGTCTTCGA
GGTGCCCAGGCTGCCTCCCCAGCCAAAGGGGAGCCGTCACTGCCCGAGAAGGACGAGGAC
CATGCACTGAGTTACTGGAAGCCCTTCCTGGTCAACATGTGCGTGGCTACGGTCCTCACG
GCCGGCGCTTACCTCTGCTACAGGTTCCTGTTCAACAGCAACACATAG

# Drug_Target_11_General_Function:
Involved in protein tyrosine phosphatase activity

# Drug_Target_11_General_References:
11579209	Ravichandran LV, Chen H, Li Y, Quon MJ: Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. Mol Endocrinol. 2001 Oct;15(10):1768-80.
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
12802338	Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D: Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature. 2003 Jun 12;423(6941):769-73.
12802339	van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H: Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature. 2003 Jun 12;423(6941):773-7.
1739967	Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG: The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell. 1992 Feb 7;68(3):545-60.
2157211	Chernoff J, Schievella AR, Jost CA, Erikson RL, Neel BG: Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2735-9.
2164224	Brown-Shimer S, Johnson KA, Lawrence JB, Johnson C, Bruskin A, Green NR, Hill DE: Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5148-52.
2546149	Charbonneau H, Tonks NK, Kumar S, Diltz CD, Harrylock M, Cool DE, Krebs EG, Fischer EH, Walsh KA: Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5252-6.
8128219	Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1B. Science. 1994 Mar 11;263(5152):1397-404.
8491187	Flint AJ, Gebbink MF, Franza BR Jr, Hill DE, Tonks NK: Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J. 1993 May;12(5):1937-46.
9391040	Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY: Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13420-5.
9553104	Pannifer AD, Flint AJ, Tonks NK, Barford D: Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by x-ray crystallography. J Biol Chem. 1998 Apr 24;273(17):10454-62.
9922143	Groves MR, Yao ZJ, Roller PP, Burke TR Jr, Barford D: Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics. Biochemistry. 1998 Dec 22;37(51):17773-83.

# Drug_Target_11_HGNC_ID:
HGNC:9642

# Drug_Target_11_HPRD_ID:
01477

# Drug_Target_11_ID:
687

# Drug_Target_11_Locus:
20q13.1-q13.2

# Drug_Target_11_Molecular_Weight:
49967

# Drug_Target_11_Name:
Tyrosine-protein phosphatase non-receptor type 1

# Drug_Target_11_Number_of_Residues:
435

# Drug_Target_11_PDB_ID:
1A5Y

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00102	Y_phosphatase

# Drug_Target_11_Protein_Sequence:
>Tyrosine-protein phosphatase non-receptor type 1
MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLH
QEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLK
CAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWP
DFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKD
PSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLE
PPPEHIPPPPRPPKRILEPHNGKCREFFPNHQWVKEETQEDKDCPIKEEKGSPLNAAPYG
IESMSQDTEVRSRVVGGSLRGAQAASPAKGEPSLPEKDEDHALSYWKPFLVNMCVATVLT
AGAYLCYRFLFNSNT

# Drug_Target_11_Reaction:
protein tyrosine phosphate + H2O = protein tyrosine + phosphate

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
May play an important role in CKII- and p60c-src-induced signal transduction cascades

# Drug_Target_11_SwissProt_ID:
P18031

# Drug_Target_11_SwissProt_Name:
PTN1_HUMAN

# Drug_Target_11_Synonyms:
EC 3.1.3.48
PTP-1B
Protein-tyrosine phosphatase 1B

# Drug_Target_11_Theoretical_pI:
6.21

# Drug_Target_11_Transmembrane_Regions:
409-431

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
M15660

# Drug_Target_12_GenBank_ID_Protein:
143306

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
Not Available

# Drug_Target_12_Gene_Sequence:
>1017 bp
ATGTTAGGTTGCAGTAGCTTATCAATTCGTACAACAGATGATAAAAGTTTATTCGCTCGC
ACAATGGATTTTACAATGGAACCAGATAGTAAAGTGATTATTGTCCCACGTAATTACGGC
ATTCGATTGTTAGAAAAAGAAAATGTAGTCATTAACAATTCATATGCTTTTGTTGGAATG
GGAAGCACTGACATTACATCACCAGTTCTCTATGATGGGGTAAACGAAAAGGGATTAATG
GGCGCAATGCTTTACTATGCTACATTTGCGACTTATGCTGACGAACCTAAAAAAGGCACA
ACAGGCATCAATCCCGTGTATGTAATTTCTCAAGTTTTAGGAAATTGTGTAACTGTCGAT
GATGTTATTGAAAAATTAACTTCTTATACATTATTGAATGAGGCCAATATAATACTTGGC
TTTGCACCCCCACTTCACTATACATTTACAGATGCTTCTGGTGAATCGATTGTTATTGAA
CCGGATAAAACAGGCATTACCATTCATCGAAAAACGATTGGCGTCATGACGAATAGCCCT
GGCTATGAATGGCATCAGACAAATTTAAGAGCTTACATTGGTGTCACACCAAATCCGCCA
CAAGATATAATGATGGGAGACTTGGATTTGACACCGTTTGGGCAAGGGGCAGGGGGCTTA
GGATTACCAGGTGATTTTACGCCGTCAGCACGTTTTCTTCGGGTAGCATACTGGAAAAAA
TATACTGAAAAAGCCAAAAATGAAACAGAAGGCGTAACAAACTTGTTCCATATTCTATCT
TCTGTAAATATCCCAAAAGGTGTTGTTTTGACAAATGAGGGGAAAACGGATTATACCATC
TATACCTCAGCTATGTGTGCACAAAGTAAAAACTATTACTTTAAACTGTATGACAATAGT
CGAATTTCAGCCGTTTCCTTAATGGCTGAAAATTTAAATAGTCAAGATTTAATTACATTT
GAGTGGGATCGTAAACAAGATATTAAGCAATTAAATCAAGTAAATGTAATGAGCTAA

# Drug_Target_12_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_12_General_References:
3026906	Olsson A, Uhlen M: Sequencing and heterologous expression of the gene encoding penicillin V amidase from Bacillus sphaericus. Gene. 1986;45(2):175-81.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
2385

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
37458

# Drug_Target_12_Name:
Penicillin acylase

# Drug_Target_12_Number_of_Residues:
338

# Drug_Target_12_PDB_ID:
3PVA

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF02275	CBAH

# Drug_Target_12_Protein_Sequence:
>Penicillin acylase precursor
MLGCSSLSIRTTDDKSLFARTMDFTMEPDSKVIIVPRNYGIRLLEKENVVINNSYAFVGM
GSTDITSPVLYDGVNEKGLMGAMLYYATFATYADEPKKGTTGINPVYVISQVLGNCVTVD
DVIEKLTSYTLLNEANIILGFAPPLHYTFTDASGESIVIEPDKTGITIHRKTIGVMTNSP
GYEWHQTNLRAYIGVTPNPPQDIMMGDLDLTPFGQGAGGLGLPGDFTPSARFLRVAYWKK
YTEKAKNETEGVTNLFHILSSVNIPKGVVLTNEGKTDYTIYTSAMCAQSKNYYFKLYDNS
RISAVSLMAENLNSQDLITFEWDRKQDIKQLNQVNVMS

# Drug_Target_12_Reaction:
penicillin + H2O = a carboxylate + 6-aminopenicillanate

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
The enzyme catalyzes the conversion of penicillin to 6- aminopenicillanate The precursor, furthermore, acts as a self- processing peptidase that cleaves off the propeptide. All peptidase activity is lost on conversion to the mature peptidase

# Drug_Target_12_SwissProt_ID:
P12256

# Drug_Target_12_SwissProt_Name:
PAC_BACSH

# Drug_Target_12_Synonyms:
EC 3.5.1.11
PVA
Penicillin V amidase
Penicillin acylase precursor

# Drug_Target_12_Theoretical_pI:
5.02

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Not Available

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
AF008220

# Drug_Target_13_GenBank_ID_Protein:
2293157

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
luxS

# Drug_Target_13_Gene_Sequence:
>474 bp
ATGCCTTCAGTAGAAAGTTTTGAGCTTGATCATAATGCGGTTGTTGCTCCATATGTAAGA
CATTGCGGCGTGCATAAAGTGGGAACAGACGGCGTTGTAAATAAATTTGACATTCGTTTT
TGCCAGCCAAATAAACAGGCGATGAAGCCTGACACCATTCACACACTCGAGCATTTGCTC
GCGTTTACGATTCGTTCTCACGCTGAGAAATACGATCATTTTGATATCATTGATATTTCT
CCAATGGGCTGCCAGACAGGCTATTATCTAGTTGTGAGCGGAGAGCCGACATCAGCGGAA
ATCGTTGATCTGCTTGAAGACACAATGAAGGAAGCGGTAGAGATTACAGAAATACCTGCT
GCGAATGAAAAGCAGTGCGGCCAAGCGAAGCTTCATGATCTGGAAGGCGCTAAACGTTTA
ATGCGTTTCTGGCTTTCACAGGATAAAGAAGAATTGCTAAAAGTATTTGGCTAA

# Drug_Target_13_General_Function:
Signal transduction mechanisms

# Drug_Target_13_General_References:
11553770	Hilgers MT, Ludwig ML: Crystal structure of the quorum-sensing protein LuxS reveals a catalytic metal site. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11169-74. Epub 2001 Sep 11.
11601850	Ruzheinikov SN, Das SK, Sedelnikova SE, Hartley A, Foster SJ, Horsburgh MJ, Cox AG, McCleod CW, Mekhalfia A, Blackburn GM, Rice DW, Baker PJ: The 1.2 A structure of a novel quorum-sensing protein, Bacillus subtilis LuxS. J Mol Biol. 2001 Oct 12;313(1):111-22.
12705835	Zhu J, Dizin E, Hu X, Wavreille AS, Park J, Pei D: S-Ribosylhomocysteinase (LuxS) is a mononuclear iron protein. Biochemistry. 2003 Apr 29;42(16):4717-26.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9387221	Lapidus A, Galleron N, Sorokin A, Ehrlich SD: Sequencing and functional annotation of the Bacillus subtilis genes in the 200 kb rrnB-dnaB region. Microbiology. 1997 Nov;143 ( Pt 11):3431-41.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
2725

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
17714

# Drug_Target_13_Name:
S-ribosylhomocysteine lyase

# Drug_Target_13_Number_of_Residues:
157

# Drug_Target_13_PDB_ID:
1IE0

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF02664	LuxS

# Drug_Target_13_Protein_Sequence:
>S-ribosylhomocysteine lyase
MPSVESFELDHNAVVAPYVRHCGVHKVGTDGVVNKFDIRFCQPNKQAMKPDTIHTLEHLL
AFTIRSHAEKYDHFDIIDISPMGCQTGYYLVVSGEPTSAEIVDLLEDTMKEAVEITEIPA
ANEKQCGQAKLHDLEGAKRLMRFWLSQDKEELLKVFG

# Drug_Target_13_Reaction:
S-(5-deoxy-D-ribos-5-yl)-L-homocysteine = L-homocysteine + (4S)-4,5-dihydroxypentan-2,3-dione

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Involved in the synthesis of autoinducer 2 (AI-2) which is secreted by bacteria and is used to communicate both the cell density and the metabolic potential of the environment. The regulation of gene expression in response to changes in cell density is called quorum sensing. Catalyzes the transformation of S-ribosylhomocysteine (RHC) to homocysteine (HC) and 4,5- dihydroxy-2,3-pentadione (DPD)

# Drug_Target_13_SwissProt_ID:
O34667

# Drug_Target_13_SwissProt_Name:
LUXS_BACSU

# Drug_Target_13_Synonyms:
AI-2 synthesis protein
Autoinducer-2 production protein luxS
EC 4.4.1.21

# Drug_Target_13_Theoretical_pI:
5.25

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Not Available

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
X03016

# Drug_Target_14_GenBank_ID_Protein:
15387

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
1

# Drug_Target_14_Gene_Sequence:
>726 bp
ATGAAACTAATCTTTTTAAGCGGTGTAAAGCGTAGTGGAAAAGATACTACTGCTGATTTT
ATCATGAGCAATTATTCTGCAGTTAAATACCAACTTGCTGGTCCTATTAAGGATGCATTG
GCTTATGCATGGGGAGTATTTGCAGCAAACACTGACTATCCTTGCTTAACTCGTAAAGAG
TTTGAAGGAATTGACTATGATCGTGAGACTAATTTAAATCTGACTAAATTAGAAGTAATC
ACGATTATGGAACAAGCATTTTGTTATCTTAATGGTAAAAGCCCAATTAAAGGTGTGTTT
GTTTTTGATGACGAAGGAAAAGAATCAGTTAATTTCGTAGCATTTAATAAGATTACTGAC
GTTATAAATAATATTGAAGATCAATGGTCAGTCCGTCGTCTGATGCAAGCCCTAGGTACG
GATTTGATTGTTAATAACTTCGACCGCATGTACTGGGTAAAATTATTTGCTTTAGATTAT
CTTGATAAATTTAACTCAGGTTATGATTATTATATCGTTCCTGATACCCGTCAAGATCAT
GAAATGGATGCGGCTAGGGCGATGGGTGCTACAGTAATTCATGTAGTTCGTCCTGGTCAA
AAATCCAATGATACACATATTACAGAAGCTGGATTGCCAATTCGTGATGGCGATTTAGTA
ATTACAAACGATGGTTCTCTTGAAGAACTTTTTTCTAAAATTAAAAATACACTAAAGGTA
CTATAA

# Drug_Target_14_General_Function:
Involved in (deoxy)nucleoside-phosphate kinase activity

# Drug_Target_14_General_References:
12626685	Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Ruger W: Bacteriophage T4 genome. Microbiol Mol Biol Rev. 2003 Mar;67(1):86-156, table of contents.
2740234	Koch T, Lamm N, Ruger W: Sequencing, cloning and overexpression of genes of bacteriophage T4 between map positions 74.325 and 77.184. Nucleic Acids Res. 1989 Jun 12;17(11):4392.
4057254	Broida J, Abelson J: Sequence organization and control of transcription in the bacteriophage T4 tRNA region. J Mol Biol. 1985 Oct 5;185(3):545-63.
7063418	Herrmann R: Nucleotide sequence of the bacteriophage T4 gene 57 and a deduced amino acid sequence. Nucleic Acids Res. 1982 Feb 11;10(3):1105-12.
8670851	Teplyakov A, Sebastiao P, Obmolova G, Perrakis A, Brush GS, Bessman MJ, Wilson KS: Crystal structure of bacteriophage T4 deoxynucleotide kinase with its substrates dGMP and ATP. EMBO J. 1996 Jul 15;15(14):3487-97.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
3596

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
27329

# Drug_Target_14_Name:
Deoxynucleotide monophosphate kinase

# Drug_Target_14_Number_of_Residues:
241

# Drug_Target_14_PDB_ID:
1DEL

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
Not Available

# Drug_Target_14_Protein_Sequence:
>Deoxynucleotide monophosphate kinase
MKLIFLSGVKRSGKDTTADFIMSNYSAVKYQLAGPIKDALAYAWGVFAANTDYPCLTRKE
FEGIDYDRETNLNLTKLEVITIMEQAFCYLNGKSPIKGVFVFDDEGKESVNFVAFNKITD
VINNIEDQWSVRRLMQALGTDLIVNNFDRMYWVKLFALDYLDKFNSGYDYYIVPDTRQDH
EMDAARAMGATVIHVVRPGQKSNDTHITEAGLPIRDGDLVITNDGSLEELFSKIKNTLKV
L

# Drug_Target_14_Reaction:
ATP + deoxynucleoside phosphate = ADP + deoxynucleoside diphosphate

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
Acts on dGMP, dTMP and 5-hydroxymethyl-dCMP while excluding dCMP and dAMP

# Drug_Target_14_SwissProt_ID:
P04531

# Drug_Target_14_SwissProt_Name:
DNMK_BPT4

# Drug_Target_14_Synonyms:
DNK
EC 2.7.4.13
Gp1
dNMP kinase

# Drug_Target_14_Theoretical_pI:
4.85

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Centrosome

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
CDC25B

# Drug_Target_15_GenBank_ID_Gene:
M81934

# Drug_Target_15_GenBank_ID_Protein:
180173

# Drug_Target_15_GeneCard_ID:
CDC25B

# Drug_Target_15_Gene_Name:
CDC25B

# Drug_Target_15_Gene_Sequence:
>1701 bp
ATGGAGGTGCCCCAGCCGGAGCCCGCGCCAGGCTCGGCTCTCAGTCCAGCAGGCGTGTGC
GGTGGCGCCCAGCGTCCGGGCCACCTCCCGGGCCTCCTGCTGGGATCTCATGGCCTCCTG
GGGTCCCCGGTGCGGGCGGCCGCTTCCTCGCCGGTCACCACCCTCACCCAGACCATGCAC
GACCTCGCCGGGCTCGGCAGCCGCAGCCGCCTGACGCACCTATCCCTGTCTCGACGGGCA
TCCGAATCCTCCCTGTCGTCTGAATCCTCCGAATCTTCTGATGCAGGTCTCTGCATGGAT
TCCCCCAGCCCTATGGACCCCCACATGGCGGAGCAGACGTTTGAACAGGCCATCCAGGCA
GCCAGCCGGATCATTCGAAACGAGCAGTTTGCCATCAGACGCTTCCAGTCTATGCCGGTG
AGGCTGCTGGGCCACAGCCCCGTGCTTCGGAACATCACCAACTCCCAGGCGCCCGACGGC
CGGAGGAAGAGCGAGGCGGGCAGTGGAGCTGCCAGCAGCTCTGGGGAAGACAAGGAGAAT
GATGGATTTGTCTTCAAGATGCCATGGAAGCCCACACATCCCAGCTCCACCCATGCTCTG
GCAGAGTGGGCCAGCCGCAGGGAAGCCTTTGCCCAGAGACCCAGCTCGGCCCCCGACCTG
ATGTGTCTCAGTCCTGACCGGAAGATGGAAGTGGAGGAGCTCAGCCCCCTGGCCCTAGGT
CGCTTCTCTCTGACCCCTGCAGAGGGGGATACTGAGGAAGATGATGGATTTGTGGACATC
CTAGAGAGTGACTTAAAGGATGATGATGCAGTTCCCCCAGGCATGGAGAGTCTCATTAGT
GCCCCACTGGTCAAGACCTTGGAAAAGGAAGAGGAAAAGGACCTCGTCATGTACAGCAAG
TGCCAGCGGCTCTTCCGCTCTCCGTCCATGCCCTGCAGCGTGATCCGGCCCATCCTCAAG
AGGCTGGAGCGGCCCCAGGACAGGGACACGCCCGTGCAGAATAAGCGGAGGCGGAGCGTG
ACCCCTCCTGAGGAGCAGCAGGAGGCTGAGGAACCTAAAGCCCGCGTCCTCCGCTCAAAA
TCACTGTGTCACGATGAGATCGAGAACCTCCTGGACAGTGACCACCGAGAGCTGATTGGA
GATTACTCTAAGGCCTTCCTCCTACAGACAGTAGACGGAAAGCACCAAGACCTCAAGTAC
ATCTCACCAGAAACGATGGTGGCCCTATTGACGGGCAAGTTCAGCAACATCGTGGATAAG
TTTGTGATTGTAGACTGCAGATACCCCTATGAATATGAAGGCGGGCACATCAAGACTGCG
GTGAACTTGCCCCTGGAACGCGACGCCGAGAGCTTCCTACTGAAGAGCCCCATCGCGCCC
TGTAGCCTGGACAAGAGAGTCATCCTCATTTTCCACTGTGAATTCTCATCTGAGCGTGGG
CCCCGCATGTGCCGTTTCATCAGGGAACGAGACCGTGCTGTCAACGACTACCCCAGCCTC
TACTACCCTGAGATGTATATCCTGAAAGGCGGCTACAAGGAGTTCTTCCCTCAGCACCCG
AACTTCTGTGAACCCCAGGACTACCGGCCCATGAACCACGAGGCCTTCAAGGATGAGCTA
AAGACCTTCCGCCTCAAGACTCGCAGCTGGGCTGGGGAGCGGAGCCGGCGGGAGCTCTGT
AGCCGGCTGCAGGACCAGTGA

# Drug_Target_15_General_Function:
Involved in protein tyrosine phosphatase activity

# Drug_Target_15_General_References:
10543950	Reynolds RA, Yem AW, Wolfe CL, Deibel MR Jr, Chidester CG, Watenpaugh KD: Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol. 1999 Oct 29;293(3):559-68.
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
1662986	Nagata A, Igarashi M, Jinno S, Suto K, Okayama H: An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol. 1991 Oct;3(10):959-68.
1836978	Galaktionov K, Beach D: Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell. 1991 Dec 20;67(6):1181-94.
9188863	Baldin V, Cans C, Superti-Furga G, Ducommun B: Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? Oncogene. 1997 May 22;14(20):2485-95.

# Drug_Target_15_HGNC_ID:
HGNC:1726

# Drug_Target_15_HPRD_ID:
00307

# Drug_Target_15_ID:
3105

# Drug_Target_15_Locus:
20p13

# Drug_Target_15_Molecular_Weight:
64988

# Drug_Target_15_Name:
M-phase inducer phosphatase 2

# Drug_Target_15_Number_of_Residues:
580

# Drug_Target_15_PDB_ID:
1CWR

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF00581	Rhodanese
PF06617	M-inducer_phosp

# Drug_Target_15_Protein_Sequence:
>M-phase inducer phosphatase 2
MEVPQPEPAPGSALSPAGVCGGAQRPGHLPGLLLGSHGLLGSPVRAAASSPVTTLTQTMH
DLAGLGSETPKSQVGTLLFRSRSRLTHLSLSRRASESSLSSESSESSDAGLCMDSPSPMD
PHMAEQTFEQAIQAASRIIRNEQFAIRRFQSMPVRLLGHSPVLRNITNSQAPDGRRKSEA
GSGAASSSGEDKENDGFVFKMPWKPTHPSSTHALAEWASRREAFAQRPSSAPDLMCLSPD
RKMEVEELSPLALGRFSLTPAEGDTEEDDGFVDILESDLKDDDAVPPGMESLISAPLVKT
LEKEEEKDLVMYSKCQRLFRSPSMPCSVIRPILKRLERPQDRDTPVQNKRRRSVTPPEEQ
QEAEEPKARVLRSKSLCHDEIENLLDSDHRELIGDYSKAFLLQTVDGKHQDLKYISPETM
VALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAESFLLKSPIAPCSLDKR
VILIFHCEFSSERGPRMCRFIRERDRAVNDYPSLYYPEMYILKGGYKEFFPQHPNFCEPQ
DYRPMNHEAFKDELKTFRLKTRSWAGERSRRELCSRLQDQ

# Drug_Target_15_Reaction:
protein tyrosine phosphate + H2O = protein tyrosine + phosphate

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression. Directly dephosphorylates CDC2 and stimulates its kinase activity. The three isoforms seem to have a different level of activity

# Drug_Target_15_SwissProt_ID:
P30305

# Drug_Target_15_SwissProt_Name:
MPIP2_HUMAN

# Drug_Target_15_Synonyms:
Dual specificity phosphatase Cdc25B
EC 3.1.3.48

# Drug_Target_15_Theoretical_pI:
6.36

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AF191564

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
blaVIM-2

# Drug_Target_1_Gene_Sequence:
>801 bp
ATGTTCAAACTTTTGAGTAAGTTATTGGTCTATTTGACCGCGTCTATCATGGCTATTGCG
AGTCCGCTCGCTTTTTCCGTAGATTCTAGCGGTGAGTATCCGACAGTCAGCGAAATTCCG
GTCGGGGAGGTCCGGCTTTACCAGATTGCCGATGGTGTTTGGTCGCATATCGCAACGCAG
TCGTTTGATGGCGCAGTCTACCCGTCCAATGGTCTCATTGTCCGTGATGGTGATGAGTTG
CTTTTGATTGATACAGCGTGGGGTGCGAAAAACACAGCGGCACTTCTCGCGGAGATTGAG
AAGCAAATTGGACTTCCTGTAACGCGTGCAGTCTCCACGCACTTTCATGACGACCGCGTC
GGCGGCGTTGATGTCCTTCGGGCGGCTGGGGTGGCAACGTACGCATCACCGTCGACACGC
CGGCTAGCCGAGGTAGAGGGGAACGAGATTCCCACGCACTCTCTAGAAGGACTCTCATCG
AGCGGGGACGCAGTGCGCTTCGGTCCAGTAGAACTCTTCTATCCTGGTGCTGCGCATTCG
ACCGACAACTTAGTTGTGTACGTCCCGTCTGCGAGTGTGCTCTATGGTGGTTGTGCGATT
TATGAGTTGTCACGCACGTCTGCGGGGAACGTGGCCGATGCCGATCTGGCTGAATGGCCC
ACCTCCATTGAGCGGATTCAACAACACTACCCGGAAGCACAGTTCGTCATTCCGGGGCAC
GGCCTGCCGGGCGGTCTAGACTTGCTCAAGCACACAACGAATGTTGTAAAAGCGCACACA
AATCGCTCAGTCGTTGAGTAG

# Drug_Target_1_General_Function:
Involved in hydrolase activity

# Drug_Target_1_General_References:
10722487	Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P: Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000 Apr;44(4):891-7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5365

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
28327

# Drug_Target_1_Name:
Metallo beta-lactamase

# Drug_Target_1_Number_of_Residues:
266

# Drug_Target_1_PDB_ID:
1KO3

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00753	Lactamase_B

# Drug_Target_1_Protein_Sequence:
>Metallo beta-lactamase
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q9K2N0

# Drug_Target_1_SwissProt_Name:
Q9K2N0_PSEAE

# Drug_Target_1_Synonyms:
Beta-lactamase
Beta-lactamase VIM-2
Metallo-beta-lactamase VIM-2
Mettalo-beta-lactamase VIM-2
VIM-2
VIM-2 beta-lactamase
VIM-2 metallo-beta-lactamase
VIM-2 type metallo-beta-lactamase

# Drug_Target_1_Theoretical_pI:
4.81

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE000512

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
TM_1080

# Drug_Target_2_Gene_Sequence:
>432 bp
TTAAACCTCATCGATCTTTCTGATTCTCCTTTCGTGCCTTCCTCCATCGAAGGGTGTTGA
AAGGAAGGTATCCACTATCCAGAAAGCGAGCTCTGCTCCGATGAGCCTTCCCGGAAGAAC
GAGGATGTTTGCATTGTTGTGCGATCTCGCGAGTCTTGCCATGTCCGGGAAAAGACAGAG
AGCTGCTCTTATGCCCCTGTACCTGTTTGCAGCAATTGACATCCCGAGCCCTGTCCCACA
CAAAAGGATTCCAAAATCCGCTTCGTTCGACAGAATGGATTGAACAACTTTTTTTGCGTA
GTCCGGATAATCAACGGATTCCTCGGAATAGGTACCGTGATCTTCCACTTCTATTCCCTT
GCCCAGAAGGTAGTTCTTCACCTTCTCTTTCAGTTCAAAAGCTGCGTGGTCCGATGCAAT
AGCGATCTTCAC

# Drug_Target_2_General_Function:
Involved in rhodopsin-like receptor activity

# Drug_Target_2_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5366

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
15867

# Drug_Target_2_Name:
Sugar-phosphate isomerase

# Drug_Target_2_Number_of_Residues:
143

# Drug_Target_2_PDB_ID:
1O1X

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02502	LacAB_rpiB

# Drug_Target_2_Protein_Sequence:
>Sugar-phosphate isomerase
MKIAIASDHAAFELKEKVKNYLLGKGIEVEDHGTYSEESVDYPDYAKKVVQSILSNEADF
GILLCGTGLGMSIAANRYRGIRAALCLFPDMARLARSHNNANILVLPGRLIGAELAFWIV
DTFLSTPFDGGRHERRIRKIDEV

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q9X0G9

# Drug_Target_2_SwissProt_Name:
Q9X0G9_THEMA

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
6.94

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Lysosome

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
CTSL

# Drug_Target_3_GenBank_ID_Gene:
X12451

# Drug_Target_3_GenBank_ID_Protein:
29715

# Drug_Target_3_GeneCard_ID:
CTSL

# Drug_Target_3_Gene_Name:
CTSL1

# Drug_Target_3_Gene_Sequence:
>1002 bp
ATGAATCCTACACTCATCCTTGCTGCCTTTTGCCTGGGAATTGCCTCAGCTACTCTAACA
TTTGATCACAGTTTAGAGGCACAGTGGACCAAGTGGAAGGCGATGCACAACAGATTATAC
GGCATGAATGAAGAAGGATGGAGGAGAGCAGTGTGGGAGAAGAACATGAAGATGATTGAA
CTGCACAATCAGGAATACAGGGAAGGGAAACACAGCTTCACAATGGCCATGAACGCCTTT
GGAGACATGACCAGTGAAGAATTCAGGCAGGTGATGAATGGCTTTCAAAACCGTAAGCCC
AGGAAGGGGAAAGTGTTCCAGGAACCTCTGTTTTATGAGGCCCCCAGATCTGTGGATTGG
AGAGAGAAAGGCTACGTGACTCCTGTGAAGAATCAGGGTCAGTGTGGTTCTTGTTGGGCT
TTTAGTGCTACTGGTGCTCTTGAAGGACAGATGTTCCGGAAAACTGGGAGGCTTATCTCA
CTGAGTGAGCAGAATCTGGTAGACTGCTCTGGGCCTCAAGGCAATGAAGGCTGCAATGGT
GGCCTAATGGATTATGCTTTCCAGTATGTTCAGGATAATGGAGGCCTGGACTCTGAGGAA
TCCTATCCATATGAGGCAACAGAAGAATCCTGTAAGTACAATCCCAAGTATTCTGTTGCT
AATGACACCGGCTTTGTGGACATCCCTAAGCAGGAGAAGGCCCTGATGAAGGCAGTTGCA
ACTGTGGGGCCCATTTCTGTTGCTATTGATGCAGGTCATGAGTCCTTCCTGTTCTATAAA
GAAGGCATTTATTTTGAGCCAGACTGTAGCAGTGAAGACATGGATCATGGTGTGCTGGTG
GTTGGCTACGGATTTGAAAGCACAGAATCAGATAACAATAAATATTGGCTGGTGAAGAAC
AGCTGGGGTGAAGAATGGGGCATGGGTGGCTACGTAAAGATGGCCAAAGACCGGAGAAAC
CATTGTGGAATTGCCTCAGCAGCCAGCTACCCCACTGTGTGA

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
12754519	Zhang H, Li XJ, Martin DB, Aebersold R: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 2003 Jun;21(6):660-6. Epub 2003 May 18.
2835398	Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP: Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts. J Clin Invest. 1988 May;81(5):1621-9.
3342889	Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V: Amino acid sequences of the human kidney cathepsins H and L. FEBS Lett. 1988 Feb 15;228(2):341-5.
3421948	Gal S, Gottesman MM: Isolation and sequence of a cDNA for human pro-(cathepsin L). Biochem J. 1988 Jul 1;253(1):303-6.
3545185	Mason RW, Walker JE, Northrop FD: The N-terminal amino acid sequences of the heavy and light chains of human cathepsin L. Relationship to a cDNA clone for a major cysteine proteinase from a mouse macrophage cell line. Biochem J. 1986 Dec 1;240(2):373-7.
3550705	Joseph L, Lapid S, Sukhatme V: The major ras induced protein in NIH3T3 cells is cathepsin L. Nucleic Acids Res. 1987 Apr 10;15(7):3186.

# Drug_Target_3_HGNC_ID:
HGNC:2537

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3858

# Drug_Target_3_Locus:
9q21-q22

# Drug_Target_3_Molecular_Weight:
37564

# Drug_Target_3_Name:
Cathepsin L

# Drug_Target_3_Number_of_Residues:
333

# Drug_Target_3_PDB_ID:
1CS8

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00112	Peptidase_C1
PF08246	Inhibitor_I29

# Drug_Target_3_Protein_Sequence:
>Cathepsin L
MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIE
LHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDW
REKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNG
GLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVA
TVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKN
SWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV

# Drug_Target_3_Reaction:
Similar to that of papain. As compared to cathepsin B, cathepsin L exhibits higher activity towards protein substrates, but has little activity on Z-Arg-Arg-NHMec, and no peptidyl-dipeptidase activity INHIBITOR E-64; Leupeptin; Z-Phe-Phe-CHN2

# Drug_Target_3_Signals:
1-17

# Drug_Target_3_Specific_Function:
Important for the overall degradation of proteins in lysosomes

# Drug_Target_3_SwissProt_ID:
P07711

# Drug_Target_3_SwissProt_Name:
CATL1_HUMAN

# Drug_Target_3_Synonyms:
Cathepsin L precursor
EC 3.4.22.15
MEP
Major excreted protein

# Drug_Target_3_Theoretical_pI:
5.14

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
S48141

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
Not Available

# Drug_Target_4_Gene_Sequence:
>1242 bp
ATGAAAATTGTTGACGTACTTTGTACACCAGGATTAACTGGATTCTATTTTGATGACCAA
AGAGCAATCAAAAAGGGAGCAGGACATGATGGATTTACATATACTGGCTCTACTGTAACA
GAAGGATTTACTCAAGTAAGACAAAAAGGTGAATCAATATCTGTATTATTAGTTCTTGAA
GATGGTCAGGTTGCTCACGGAGATTGTGCTGCAGTTCAGTACTCAGGAGCAGGCGGAAGA
GATCCATTATTCTTAGCTAAAGATTTTATACCTGTTATAGAAAAAGAAATAGCTCCAAAA
TTGATTGGAAGAGAAATAACTAACTTTAAACCAATGGCAGAAGAATTCGACAAAATGACT
GTAAATGGTAATAGATTACATACTGCTATCAGATATGGTATAACTCAGGCTATACTTGAT
GCAGTAGCTAAAACTAGAAAAGTAACTATGGCTGAAGTAATCAGAGATGAATACAATCCA
GGAGCAGAAATCAATGCAGTTCCTGTATTTGCTCAGTCAGGTGATGATAGATACGATAAC
GTTGATAAGATGATAATTAAAGAAGCTGATGTTTTACCACATGCTTTAATCAACAATGTT
GAAGAAAAATTAGGACTTAAAGGAGAAAAACTTCTTGAGTACGTTAAATGGTTAAGAGAT
AGAATAATCAAATTAAGAGTAAGAGAAGACTATGCTCCAATATTCCACATCGACGTATAT
GGAACAATCGGTGCTGCATTTGATGTTGACATCAAGGCTATGGCTGATTACATTCAGACT
TTAGCTGAAGCTGCTAAGCCATTCCACTTAAGAATTGAAGGACCAATGGACGTTGAAGAT
AGACAAAAACAAATGGAAGCTATGAGAGACTTAAGAGCTGAATTAGACGGAAGAGGAGTA
GACGCAGAATTAGTTGCTGATGAATGGTGTAATACAGTTGAAGATGTTAAATTCTTCACT
GATAACAAAGCTGGACACATGGTTCAGATCAAAACTCCAGACCTTGGTGGAGTTAACAAT
ATAGCAGATGCTATTATGTACTGTAAAGCTAACGGAATGGGAGCTTATTGTGGAGGAACT
TGTAACGAAACTAACAGATCCGCTGAAGTTACAACTAACATAGGTATGGCTTGTGGAGCT
AGACAGGTTCTTGCTAAACCAGGTATGGGTGTTGACGAAGGAATGATGATCGTTAAGAAC
GAAATGAACAGAGTTTTAGCTCTTGTAGGAAGAAGAAAATAA

# Drug_Target_4_General_Function:
Amino acid transport and metabolism

# Drug_Target_4_General_References:
1397267	Marsh EN, Holloway DE: Cloning and sequencing of glutamate mutase component S from Clostridium tetanomorphum. Homologies with other cobalamin-dependent enzymes. FEBS Lett. 1992 Sep 28;310(2):167-70.
1420191	Goda SK, Minton NP, Botting NP, Gani D: Cloning, sequencing, and expression in Escherichia coli of the Clostridium tetanomorphum gene encoding beta-methylaspartase and characterization of the recombinant protein. Biochemistry. 1992 Nov 10;31(44):10747-56.
8428631	Holloway DE, Marsh EN: Cloning and sequencing of glutamate mutase component E from Clostridium tetanomorphum. Organization of the mut genes. FEBS Lett. 1993 Feb 8;317(1-2):44-8.
8454064	Brecht M, Kellermann J, Pluckthun A: Cloning and sequencing of glutamate mutase component E from Clostridium tetanomorphum. FEBS Lett. 1993 Mar 15;319(1-2):84-9.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4699

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
45535

# Drug_Target_4_Name:
Methylaspartate ammonia-lyase

# Drug_Target_4_Number_of_Residues:
413

# Drug_Target_4_PDB_ID:
1KCZ

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF05034	MAAL_N
PF07476	MAAL_C

# Drug_Target_4_Protein_Sequence:
>Methylaspartate ammonia-lyase
MKIVDVLCTPGLTGFYFDDQRAIKKGAGHDGFTYTGSTVTEGFTQVRQKGESISVLLVLE
DGQVAHGDCAAVQYSGAGGRDPLFLAKDFIPVIEKEIAPKLIGREITNFKPMAEEFDKMT
VNGNRLHTAIRYGITQAILDAVAKTRKVTMAEVIRDEYNPGAEINAVPVFAQSGDDRYDN
VDKMIIKEADVLPHALINNVEEKLGLKGEKLLEYVKWLRDRIIKLRVREDYAPIFHIDVY
GTIGAAFDVDIKAMADYIQTLAEAAKPFHLRIEGPMDVEDRQKQMEAMRDLRAELDGRGV
DAELVADEWCNTVEDVKFFTDNKAGHMVQIKTPDLGGVNNIADAIMYCKANGMGAYCGGT
CNETNRSAEVTTNIGMACGARQVLAKPGMGVDEGMMIVKNEMNRVLALVGRRK

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
L-threo-3-methylaspartate = mesaconate + NH(3)

# Drug_Target_4_SwissProt_ID:
Q05514

# Drug_Target_4_SwissProt_Name:
MAAL_CLOTT

# Drug_Target_4_Synonyms:
Beta-methylaspartase
EC 4.3.1.2

# Drug_Target_4_Theoretical_pI:
5.13

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AY306209

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
prx

# Drug_Target_5_Gene_Sequence:
>723 bp
ATGAGAATGAGAAGAACAATACTAATATTTACTGTTATATTAATACCTCTTACTTTTTGT
TTTAAAAATGCTTTAATTAAGCATTCTATTAATATAGTATCCAAGCGAGGAAACTCGAAG
AATCGGTTTTCCCAAAAAGTTTATGAATCCAAAAATATAGATTTGGAAAATGATATAAAA
GAAAATGATCTTATTCCTAACGTGAAAGTTATGATTGACGTAAGAAATATGAACAACATA
TCTGATACCGATGGGAGCCCAAACGATTTTACTTCAATAGATACACATGAATTATTTAAT
AACAAAAAGATTTTATTAATCAGTTTACCTGGGGCATTTACGCCTACTTGCAGTACAAAA
ATGATACCAGGATATGAAGAAGAATATGATTATTTTATAAAAGAGAATAATTTTGATGAC
ATTTATTGTATTACTAATAATGATATATATGTATTAAAGAGTTGGTTTAAAAGTATGGAT
ATAAAAAAAATAAAATATATAAGTGATGGTAATAGTTCATTTACAGAAAGTATGAATATG
TTAGTAGACAAATCTAATTTTTTTATGGGAATGAGACCTTGGAGATTTGTTGCTATTGTT
GAAAATAATATTTTGGTTAAAATGTTTCAAGAAAAAGATAAACAACATAATATTCAAACA
GACCCATATGATATATCAACTGTCAATAATGTAAAAGAGTTTTTAAAAAATAATCAGTTA
TAA

# Drug_Target_5_General_Function:
Involved in oxidoreductase activity

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
5367

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
28125

# Drug_Target_5_Name:
Peroxiredoxin

# Drug_Target_5_Number_of_Residues:
240

# Drug_Target_5_PDB_ID:
1XIY

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF08534	Redoxin

# Drug_Target_5_Protein_Sequence:
>Peroxiredoxin
MRMRRTILIFTVILIPLTFCFKNALIKHSINIVSKRGNSKNRFSQKVYESKNIDLENDIK
ENDLIPNVKVMIDVRNMNNISDTDGSPNDFTSIDTHELFNNKKILLISLPGAFTPTCSTK
MIPGYEEEYDYFIKENNFDDIYCITNNDIYVLKSWFKSMDIKKIKYISDGNSSFTESMNM
LVDKSNFFMGMRPWRFVAIVENNILVKMFQEKDKQHNIQTDPYDISTVNNVKEFLKNNQL

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q5MYR6

# Drug_Target_5_SwissProt_Name:
Q5MYR6_PLAF7

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
8.03

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X79087

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
def

# Drug_Target_6_Gene_Sequence:
>579 bp
ATGGTCTACCCCATCCGGCTTTACGGAGACCCCGTCCTCCGCCGCAAGGCCCGGCCCGTG
GAGGACTTCTCGGGGATTAAGCGCCTGGCGGAGGACATGCTGGAGACGATGTTTGAGGCC
AAAGGGGTGGGGCTTGCCGCCCCCCAGATCGGCCTCTCCCAGCGCCTCTTCGTGGCGGTG
GAGTACGCCGACGAGCCCGAGGGGGAGGAGGAGAGGCCCCTGAGGGAGCTCGTGCGCCGG
GTCTACGTGGTGGCGAACCCGGTGATCACCTACCGGGAGGGACTGGTGGAGGGGACGGAG
GGGTGCCTCTCCCTGCCCGGCCTCTACTCCGAGGAGGTGCCCCGGGCGGAGCGCATCCGG
GTGGAGTACCAGGACGAGGAGGGCCGTGGGCGCGTGTTGGAGCTCGAGGGGTACATGGCC
CGGGTCTTCCAGCATGAGATCGACCATCTGGACGGGATCCTCTTCTTTGAGCGCCTGCCC
AAGCCCAAGCGGGAGGCCTTTCTGGAGGCCAACCGGGCGGAGCTCGTCCGCTTCCAGAAG
GAGGCCCGGGCCTTGCTGAAGGAGCTTTCCCAGGGATGA

# Drug_Target_6_General_Function:
Involved in iron ion binding

# Drug_Target_6_General_References:
7961514	Meinnel T, Blanquet S: Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase. J Bacteriol. 1994 Dec;176(23):7387-90.
9126850	Meinnel T, Lazennec C, Villoing S, Blanquet S: Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion. J Mol Biol. 1997 Apr 4;267(3):749-61.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
5368

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
22093

# Drug_Target_6_Name:
Peptide deformylase

# Drug_Target_6_Number_of_Residues:
192

# Drug_Target_6_PDB_ID:
1V3Y

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_6_Protein_Sequence:
>Peptide deformylase
MVYPIRLYGDPVLRRKARPVEDFSGIKRLAEDMLETMFEAKGVGLAAPQIGLSQRLFVAV
EYADEPEGEEERPLRELVRRVYVVANPVITYREGLVEGTEGCLSLPGLYSEEVPRAERIR
VEYQDEEGRGRVLELEGYMARVFQHEIDHLDGILFFERLPKPKREAFLEANRAELVRFQK
EARALLKELSQG

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_6_SwissProt_ID:
P43522

# Drug_Target_6_SwissProt_Name:
DEF_THETH

# Drug_Target_6_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_6_Theoretical_pI:
4.86

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Golgi apparatus

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
GLIPR2

# Drug_Target_7_GenBank_ID_Gene:
AJ011129

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
GLIPR2

# Drug_Target_7_Gene_Sequence:
>465 bp
ATGGGCAAGTCAGCTTCCAAACAGTTTCATAATGAGGTCCTGAAGGCCCACAATGAGTAC
CGGCAGAAGCACGGCGTCCCCCCACTGAAGCTCTGCAAGAACCTCAACCGGGAGGCTCAA
CAGTATTCTGAGGCCCTGGCCAGCACGAGGATCCTCAAGCACAGCCCGGAGTCCAGCCGT
GGCCAGTGTGGGGAGAACCTTGCATGGGCATCCTATGATCAGACAGGAAAGGAGGTGGCT
GATAGATGGTACAGTGAAATCAAGAACTATAACTTCCAGCAGCCTGGCTTCACCTCGGGG
ACTGGACACTTCACGGCCATGGTATGGAAGAACACCAAGAAGATGGGCGTGGGGAAGGCG
TCCGCAAGTGACGGGTCCTCCTTTGTGGTGGCCAGATACTTCCCAGCGGGGAATGTTGTC
AATGAGGGCTTCTTCGAAGAAAACGTCCTGCCGCCGAAGAAGTAA

# Drug_Target_7_General_Function:
Not Available

# Drug_Target_7_General_References:
12137952	Eisenberg I, Barash M, Kahan T, Mitrani-Rosenbaum S: Cloning and characterization of a human novel gene C9orf19 encoding a conserved putative protein with an SCP-like extracellular protein domain. Gene. 2002 Jun 26;293(1-2):141-8.

# Drug_Target_7_HGNC_ID:
HGNC:18007

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
5369

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
17218

# Drug_Target_7_Name:
Golgi-associated plant pathogenesis-related protein 1

# Drug_Target_7_Number_of_Residues:
154

# Drug_Target_7_PDB_ID:
1SMB

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00188	SCP

# Drug_Target_7_Protein_Sequence:
>Golgi-associated plant pathogenesis-related protein 1
MGKSASKQFHNEVLKAHNEYRQKHGVPPLKLCKNLNREAQQYSEALASTRILKHSPESSR
GQCGENLAWASYDQTGKEVADRWYSEIKNYNFQQPGFTSGTGHFTAMVWKNTKKMGVGKA
SASDGSSFVVARYFPAGNVVNEGFFEENVLPPKK

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
Q9H4G4

# Drug_Target_7_SwissProt_Name:
GAPR1_HUMAN

# Drug_Target_7_Synonyms:
GAPR-1
GliPR 2
Glioma pathogenesis-related protein 2
Golgi- associated PR-1 protein

# Drug_Target_7_Theoretical_pI:
9.92

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AE000512

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
TM_1158

# Drug_Target_8_Gene_Sequence:
>684 bp
GTGAGAGTGCTCGCTATTAGACACGTCGAGATAGAGGACCTTGGAATGATGGAAGATATC
TTCAGGGAGAAGAACTGGAGTTTCGATTATCTGGACACTCCAAAAGGGGAAAAACTCGAA
AGGCCTCTCGAAGAGTATTCTCTCGTGGTGCTTCTTGGAGGGTATATGGGAGCCTACGAG
GAAGAGAAATACCCTTTTTTGAAGTACGAATTTCAGTTGATAGAAGAGATCCTGAAAAAA
GAAATCCCGTTCCTTGGAATATGTCTGGGTTCTCAGATGCTCGCTAAAGTCCTTGGGGCG
AGTGTCTACAGAGGAAAAAACGGAGAAGAAATAGGCTGGTATTTTGTTGAAAAGGTCTCC
GACAATAAGTTTTTCAGAGAATTTCCAGACAGACTGCGGGTGTTTCAGTGGCATGGAGAT
ACTTTCGATCTTCCACGCAGAGCAACCAGGGTCTTTACTTCTGAAAAGTATGAAAACCAG
GGATTCGTCTATGGCAAGGCTGTGGGGCTCCAGTTCCATATAGAAGTGGGAGCCAGAACC
ATGAAACGCTGGATAGAGGCATACAAAGATGAACTTGAAAAAAAGAAGATAGATCCCAGG
CTTCTCCTTGAAACGGCGGAGAGGGAGGAAAAAGTCCTGAAAGGCCTCTTGAGGTCTCTT
TTGGAAAGGATGGTGGAAAGCTGA

# Drug_Target_8_General_Function:
Involved in catalytic activity

# Drug_Target_8_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
5370

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
26900

# Drug_Target_8_Name:
Hypothetical protein

# Drug_Target_8_Number_of_Residues:
227

# Drug_Target_8_PDB_ID:
1O1Y

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00117	GATase

# Drug_Target_8_Protein_Sequence:
>Hypothetical protein
MRVLAIRHVEIEDLGMMEDIFREKNWSFDYLDTPKGEKLERPLEEYSLVVLLGGYMGAYE
EEKYPFLKYEFQLIEEILKKEIPFLGICLGSQMLAKVLGASVYRGKNGEEIGWYFVEKVS
DNKFFREFPDRLRVFQWHGDTFDLPRRATRVFTSEKYENQGFVYGKAVGLQFHIEVGART
MKRWIEAYKDELEKKKIDPRLLLETAEREEKVLKGLLRSLLERMVES

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
Q9X0P2

# Drug_Target_8_SwissProt_Name:
Q9X0P2_THEMA

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
5.55

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasmic

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
Y10306

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
def

# Drug_Target_9_Gene_Sequence:
>495 bp
ATGTACAGAATAAGAGTCTTTGGAGATCCCGTCTTGAGAAAGAGGGCAAAACCCGTTACA
AAGTTCGACGAGAACCTGAAAAAGACCATAGAAAGAATGATAGAGACGATGTATCACTAC
GACGGTGTGGGACTCGCGGCACCGCAGGTTGGAATATCTCAGAGGTTCTTCGTCATGGAC
GTTGGAAATGGTCCGGTTGCCGTGATAAATCCGGAGATTCTTGAAATCGATCCAGAAACT
GAAGTAGCAGAAGAGGGGTGCCTCAGCTTTCCCGAGATCTTCGTCGAGATAGAAAGGAGC
AAAAGAATAAAGGTCAAATACCAGAACACAAGGGGAGAATACGTGGAAGAAGAACTGGAA
GGTTACGCTGCAAGGGTTTTTCAGCACGAGTTCGATCATCTGAACGGAGTTTTGATCATC
GATCGAATCAGTCCAGCAAAGCGCCTTTTGCTCAGAAAGAAACTCATGGACATAGCAAGA
ACCGTTAAGAGATGA

# Drug_Target_9_General_Function:
Involved in iron ion binding

# Drug_Target_9_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
9086272	Mazel D, Coic E, Blanchard S, Saurin W, Marliere P: A survey of polypeptide deformylase function throughout the eubacterial lineage. J Mol Biol. 1997 Mar 14;266(5):939-49.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
5371

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
19024

# Drug_Target_9_Name:
Peptide deformylase

# Drug_Target_9_Number_of_Residues:
164

# Drug_Target_9_PDB_ID:
1LME

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_9_Protein_Sequence:
>Peptide deformylase
MYRIRVFGDPVLRKRAKPVTKFDENLKKTIERMIETMYHYDGVGLAAPQVGISQRFFVMD
VGNGPVAVINPEILEIDPETEVAEEGCLSFPEIFVEIERSKRIKVKYQNTRGEYVEEELE
GYAARVFQHEFDHLNGVLIIDRISPAKRLLLRKKLMDIARTVKR

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_9_SwissProt_ID:
P96113

# Drug_Target_9_SwissProt_Name:
DEF_THEMA

# Drug_Target_9_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_9_Theoretical_pI:
8.43

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03661
